Literature DB >> 24642521

Bacterial lung infections in cystic fibrosis patients: an update.

Elena Chiappini1, Giovanni Taccetti, Maurizio de Martino.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24642521     DOI： 10.1097/INF.0000000000000347

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  9 in total

1.  Resurrecting Old β-Lactams: Potent Inhibitory Activity of Temocillin against Multidrug-Resistant Burkholderia Species Isolates from the United States.

Authors:  Elise T Zeiser; Scott A Becka; Melissa D Barnes; Magdalena A Taracila; John J LiPuma; Krisztina M Papp-Wallace
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

2.  Exploring the Role of the Ω-Loop in the Evolution of Ceftazidime Resistance in the PenA β-Lactamase from Burkholderia multivorans, an Important Cystic Fibrosis Pathogen.

Authors:  Krisztina M Papp-Wallace; Scott A Becka; Magdalena A Taracila; Elise T Zeiser; Julian A Gatta; John J LiPuma; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

3.  A Novel In Vitro Wound Healing Assay to Evaluate Cell Migration.

Authors:  Floriana Cappiello; Bruno Casciaro; Maria Luisa Mangoni
Journal:  J Vis Exp       Date:  2018-03-17       Impact factor: 1.355

4.  Transcriptional and Mutational Profiling of an Aminoglycoside-Resistant Pseudomonas aeruginosa Small-Colony Variant.

Authors:  Monika Schniederjans; Michal Koska; Susanne Häussler
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

5.  "Switching Partners": Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant Burkholderia cepacia Complex and Burkholderia gladioli Cystic Fibrosis Isolates.

Authors:  Elise T Zeiser; Scott A Becka; Brigid M Wilson; Melissa D Barnes; John J LiPuma; Krisztina M Papp-Wallace
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

6.  The Class A β-Lactamase Produced by Burkholderia Species Compromises the Potency of Tebipenem against a Panel of Isolates from the United States.

Authors:  Scott A Becka; Elise T Zeiser; John J LiPuma; Krisztina M Papp-Wallace
Journal:  Antibiotics (Basel)       Date:  2022-05-17

7.  Esculentin-1a-Derived Peptides Promote Clearance of Pseudomonas aeruginosa Internalized in Bronchial Cells of Cystic Fibrosis Patients and Lung Cell Migration: Biochemical Properties and a Plausible Mode of Action.

Authors:  Floriana Cappiello; Antonio Di Grazia; Li-Av Segev-Zarko; Silvia Scali; Loretta Ferrera; Luis Galietta; Alessandro Pini; Yechiel Shai; Y Peter Di; Maria Luisa Mangoni
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

8.  Characterization of the AmpC β-Lactamase from Burkholderia multivorans.

Authors:  Scott A Becka; Elise T Zeiser; Melissa D Barnes; Magdalena A Taracila; Kevin Nguyen; Indresh Singh; Granger G Sutton; John J LiPuma; Derrick E Fouts; Krisztina M Papp-Wallace
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

9.  Sequence heterogeneity of the PenA carbapenemase in clinical isolates of Burkholderia multivorans.

Authors:  Scott A Becka; Elise T Zeiser; Steven H Marshall; Julian A Gatta; Kevin Nguyen; Indresh Singh; Chris Greco; Granger G Sutton; Derrick E Fouts; John J LiPuma; Krisztina M Papp-Wallace
Journal:  Diagn Microbiol Infect Dis       Date:  2018-06-18       Impact factor: 2.803
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.